Pulsenmore Ltd Asset Turnover Ratio (PLSM), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Pulsenmore Ltd   (PLSM)
 

Pulsenmore Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pulsenmore Ltd asset turnover ratio, the ability of Pulsenmore Ltd 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.39 in the fourth quarter (Dec 31 2025), PLSM's balance sheet remain strong.

Within sector Pulsenmore Ltd achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition



PLSM Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Asset Change - - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.39 - - - -
PLSM's Total Ranking # # # # #
Seq. Asset Change -0 % 0 % 0 % - -
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Phibro Animal Health Corporation  1.08 $ 1,465.016  Millions$ 1,356.146  Millions
Esperion Therapeutics Inc   1.07 $ 403.135  Millions$ 375.255  Millions
Myomo Inc   1.07 $ 40.888  Millions$ 38.063  Millions
Axogen inc   1.07 $ 225.208  Millions$ 209.926  Millions
Vaso Corporation  1.07 $ 89.096  Millions$ 83.330  Millions
Apellis Pharmaceuticals Inc   1.07 $ 1,003.782  Millions$ 940.664  Millions
Treace Medical Concepts Inc   1.06 $ 212.690  Millions$ 199.865  Millions
Myriad Genetics Inc   1.06 $ 823.600  Millions$ 779.525  Millions
Neuronetics Inc   1.05 $ 148.308  Millions$ 140.914  Millions
Premier Air Charter Holdings Inc   1.05 $ 31.878  Millions$ 30.459  Millions
Rigel Pharmaceuticals Inc  1.03 $ 294.282  Millions$ 284.709  Millions
Regen Biopharma Inc   1.03 $ 0.237  Millions$ 0.229  Millions
Spero Therapeutics Inc   1.02 $ 66.802  Millions$ 65.729  Millions
Quipt Home Medical Corp   1.01 $ 264.974  Millions$ 261.171  Millions
Argenx Se  1.01 $ 8,399.366  Millions$ 8,305.922  Millions
Biodesix Inc   1.01 $ 88.499  Millions$ 87.545  Millions
Milestone Scientific Inc   1.01 $ 8.408  Millions$ 8.358  Millions
Nrc Health  1.00 $ 137.390  Millions$ 136.790  Millions
National Vision Holdings Inc   1.00 $ 1,987.488  Millions$ 1,980.214  Millions
Arcutis Biotherapeutics Inc   1.00 $ 376.072  Millions$ 375.122  Millions
Addus Homecare Corp  1.00 $ 1,421.874  Millions$ 1,419.190  Millions
Nexgel Inc   1.00 $ 10.509  Millions$ 10.557  Millions
Ensign Group Inc  0.99 $ 5,057.841  Millions$ 5,094.886  Millions
Omada Health Inc   0.99 $ 259.186  Millions$ 261.685  Millions
Kiniksa Pharmaceuticals International Plc  0.99 $ 677.564  Millions$ 684.111  Millions
Axsome Therapeutics Inc   0.98 $ 638.496  Millions$ 648.878  Millions
Orthofix Medical Inc   0.98 $ 822.017  Millions$ 835.890  Millions
National Healthcare Corp  0.98 $ 1,517.781  Millions$ 1,552.401  Millions
Ensysce Biosciences Inc   0.97 $ 5.067  Millions$ 5.205  Millions
Alphatec Holdings Inc   0.97 $ 763.888  Millions$ 788.556  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.